Doctor profile · Federal record
Dr. MARCO GONZALEZ, M.D.
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Student in an Organized Health Care Education/Training Program · MIAMI, FL
- NPI 1730322116
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 17 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
900 NW 17TH ST
MIAMI, FL 331361119
(305) 326-6000
Credentials & registration
- NPI registered
- April 2009 — 17 yrs on file
- Profile last updated
- September 8, 2014
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Florida #ME115882
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1730322116. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
36,060
Distinct HCPCS
10
Medicare allowed
$4,684,924
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 17,225 | 64 | $36 | |
92134 |
Imaging of retina | 3,597 | 1,330 | $41 | |
J0178 |
Injection, aflibercept, 1 mg | 2,884 | 326 | $871 | |
67028 |
Injection of drug into eye | 2,483 | 517 | $121 | |
92014 |
Established patient complete exam of visual system | 2,136 | 1,178 | $128 | |
92012 |
Established patient problem focused exam of visual system | 1,552 | 614 | $92 | |
92202 |
Extended exam of the back part of the eye with optic nerve drawing | 1,321 | 1,077 | $16 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 1,020 | 45 | $228 | |
92250 |
Photography of the retina | 873 | 836 | $38 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 860 | 833 | $133 |
In context: peer comparison
Among 60 peers in this city , average services per provider: 196. This provider delivers 184× the peer median.Open Payments
Industry payments received
All-time total
$586
Transactions
19
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 5 | $157.11 | |
| Genentech USA, Inc. | 1 | $125.00 | |
| ABBVIE INC. | 3 | $66.14 | |
| Astellas Pharma US Inc | 2 | $60.95 | |
| Notal Vision, Inc. | 2 | $39.23 | |
| Ocular Therapeutix, Inc. | 1 | $29.29 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $27.48 | |
| Harrow Eye, LLC | 1 | $25.05 | |
| Amgen Inc. | 1 | $21.63 | |
| Oyster Point Pharma, Inc. | 1 | $19.64 | |
| Bausch & Lomb Americas Inc. | 1 | $14.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
475
Patients
183
Total drug cost
$60,015
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 160 | 49 | $2,916 |
| Prednisolone Acetate | Generic | 91 | 50 | $4,387 |
| Timolol Maleate | Generic | 68 | 33 | $800 |
| Restasis (Cyclosporine) | Brand | 31 | 15 | $44,456 |
| Polymyxin B Sul-Trimethoprim (Polymyxin B Sulf/Trimethoprim) | Brand | 27 | 22 | $272 |
| Brimonidine Tartrate | Generic | 23 | 0 | $423 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 20 | 0 | $5,466 |
| Atropine Sulfate | Generic | 16 | 0 | $677 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 14 | 14 | $207 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 13 | 0 | $234 |